Home Based Daratumumab Administration for Patients With Multiple Myeloma

Clinical trial NCT05511428 · COMPLETED

Trial details

NCT number: NCT05511428
Sponsor: Thomas Jefferson University
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Plasma Cell Myeloma

Start date: 2022-11-08
Primary completion: 2024-05-22
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.